Depo-Medrol · DIN 00030759 · 40 mg/mL · injection suspension-1mL Pk
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Depo-Medrol · DIN 00030759
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2004-01-08 · brand DEPO-MEDROL · ATC H02AB04 METHYLPREDNISOLONE · form Suspension · route Intrasynovial, Intralesional, Intra-articular, Intramuscular · ingredients METHYLPREDNISOLONE ACETATE 40 MG/ML · company Pfizer canada ulc · schedule Prescription
Depo-Medrol: Formulary list price $6.88 per unit (the source does not state the unit; exact figure $6.8762). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00030759)
Source record
DIN 00030759: Depo-Medrol
Raw flags: sec3=Y
Item: 680400025; group id 716; item number 1768; lccId None; manufacturer id PFI
Source form: Inj Susp-1mL Pk; strength: 40mg/mL
Recorded listing: General benefit
Source prices (unrounded): $6.8762; ministry $6.8762
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00030759
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1134
Shortage status: not checked (no credentials)